XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements Of Income - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue:      
Total revenue $ 8,352.1 $ 7,124.1 $ 6,222.2
Cost of revenue:      
Total cost of revenue 2,717.9 2,394.6 2,026.2
Gross profit 5,634.2 4,729.5 4,196.0
Operating expenses:      
Selling, general and administrative 2,140.0 1,963.9 1,739.9
Research and development 1,145.3 998.8 879.0
Total operating expenses 3,285.3 2,962.7 2,618.9
Income from operations 2,348.9 1,766.8 1,577.1
Interest and other income, net 324.9 192.1 29.7
Income before taxes 2,673.8 1,958.9 1,606.8
Income tax expense 336.3 141.6 262.4
Net income 2,337.5 1,817.3 1,344.4
Less: net income attributable to noncontrolling interest in joint venture 14.9 19.3 22.1
Net income attributable to Intuitive Surgical, Inc. $ 2,322.6 $ 1,798.0 $ 1,322.3
Net income per share attributable to Intuitive Surgical, Inc.:      
Basic (usd per share) $ 6.54 $ 5.12 $ 3.72
Diluted (usd per share) $ 6.42 $ 5.03 $ 3.65
Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:      
Basic (shares) 355.2 351.2 355.7
Diluted (shares) 362.0 357.4 362.0
Joint venture      
Operating expenses:      
Less: net income attributable to noncontrolling interest in joint venture $ 14.9 $ 19.3 $ 22.1
Product      
Revenue:      
Total revenue 7,045.0 5,956.3 5,198.0
Cost of revenue:      
Total cost of revenue 2,313.1 2,041.8 1,700.3
Service      
Revenue:      
Total revenue 1,307.1 1,167.8 1,024.2
Cost of revenue:      
Total cost of revenue $ 404.8 $ 352.8 $ 325.9